Found 77 results
Author Title Type [ Year(Desc)]
Filters: Author is Van Veldhuisen, P  [Clear All Filters]
A. L. Schwartz, Van Veldhuisen, P., Gaasterland, D. E., Ederer, F., Sullivan, E. K., Cyrlin, M. N., and Investigators, T. A. G. I. S., The Advanced Glaucoma Intervention Study (AGIS): 5. Encapsulated bleb after first trabeculectomy, Am J Ophthalmol, vol. 127, pp. 8-19, 1999.
T. Gonwa, Ahsan, N., Halloran, P., Stegal, M., Hardy, M., Metzgar, R., Shield, III, C., Rocher, L., Scandling, J., Sorensen, L., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Salm, K., Tolzman, D., and Fitzsimmons, W., Comparative trial of Prograf™ (tacrolimus) in combination with azathiprine or mycophenolate mofetil vs. neoral (cyclosporine) with mycophenolate mofeitil after kidney transplantation, 1999.
J. Copley, Staffeld, C., Lindberg, J., Baily, C., and Van Veldhuisen, P., The conversion of kidney transplant patients to tacrolimus from cyclosporine because of refractory rejection or significant cyclosporine toxicity, 1999.
C. O. Taylor, Barr, M. L., Radovancevic, B., Renlund, D. G., Mentzer, Jr., R. M., Smart, F. W., Tolman, D. E., Frazier, O. H., Young, J. B., and Van Veldhuisen, P., A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardia transplantation: decreased hyperlipidemia and hypertension with tacrolimus, J Heart Lung Transplant, vol. 18, pp. 336-345, 1999.
R. B. Nussenblatt, Fortin, E., Schiffman, R., Rizzo, L., Smith, J., Van Veldhuisen, P., Sran, P., Yaffe, A., Goldman, C. K., Waldmann, T. A., and Whitcup, S. M., Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial, Proceedings of the National Academy of Science USA, vol. 96, pp. 7462-66, 1999.
S. Cohen, Boron, M., Cohen, A., Van Veldhuisen, P., and Registry, T. Palivizuma, Group patterns of RSV disease prophylaxis in infants with congenital heart disease (CHD): preliminary results from the 2002-2003 Palivizumab Outcomes Registry, 2003.
M. Hudak, Boron, M., Cohen, A., and Van Veldhuisen, P., Palivizumab prophylaxis of RSV disease: demographic and risk factors results from the 2002-2003 Outcomes Registry, J Perinatology, vol. 23, p. 592, 2003.
S. Cohen, Boron, M., Cohen, A., Van Veldhuisen, P., and Group, thePalivizuma, Patterns of RSV Disease Prophylaxis in Infants with Congenital Heart Disease (CHD): Preliminary Results From the 2002-2003 Palivizumab Outcomes Registry, J Perinatology, vol. 23, p. 594, 2003.
T. Gonwa, Johnson, C., Ahsan, N., Alfrey, E. J., Halloran, P., Stegall, M., Hardy, M., Metzger, R., C III, S., Rocher, L., Scandling, J., Sorensen, J., Mulloy, L., Light, J., Corwin, C., Danovitch, G., Wachs, M., Van Veldhuisen, P., Leonhardt, M., and Fitzsimmons, W. E., Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years, Transplantation, vol. 75, pp. 2048-53, 2003.
P. Van Veldhuisen, Walters, M., Sawada, T., Levine, P., Wilks, R., Hanchard, B., and Hisada, M., Seroincidence of HTLV-I infection and characterization of seroconverters in Jamaican food handlers, J Acquir Immune Defic Syndr, vol. 33, pp. 387-392, 2003.
A. K. Freeman, Linowski, G. C., Brady, C., Lind, L., Van Veldhuisen, P., Singer, G., and Lebwohl, M., Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas, J Amer Acad Dermatology, vol. 48, pp. 564-8, 2003.